Myomo® Forms Joint Venture to Manufacture and Sell the Company’s Products in China
Joint Venture intends to enter into technology agreement with upfront license fee and minimum purchase requirements CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc....
Staff
CureVac Announces Proposed Public Offering of Common Shares
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 25, 2021 / CureVac N.V. (NASDAQ:CVAC) ("CureVac" or the "Company"), a...
ReMedi Health Solutions Launches Virtual EHR Command Center for Healthcare Industry Amid the Pandemic
HOUSTON--(BUSINESS WIRE)--#EHR--ReMedi Health Solutions, an innovative healthcare IT advisory firm based in Houston, Texas, announced that it completed a virtual...
KORU Medical Systems Reports Preliminary Full Year 2020 Results; Announces CEO Transition
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) a leading medical...
Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2020 Revenue
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable...
Sanara MedTech Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2020
FORT WORTH, TX / ACCESSWIRE / January 25, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech...
MorphoSys and I-Mab Announce First Patient Dosed in U.S. Phase 1 Study of MOR210/TJ210 in Patients with Advanced Cancer
PLANEGG/MUNICH, GERMANY and SHANGHAI, CHINA / ACCESSWIRE / January 25, 2021 / MorphoSys (FSE:MOR)(Prime Standard Segment, MDAX & TecDAX)(NASDAQ:MOR) and...
Defense Department Campaigns to Cut Autism Services for Children
Report Details DoD's Misuse of Science to Make Case WASHINGTON, DC / ACCESSWIRE / January 25, 2021 / The Department...
Bloom Burton & Co. Announces the 2021 Bloom Burton Award
Annual Award Recognizes the Most Significant Contributor to Canada's Innovative Healthcare IndustryToronto, Ontario--(Newsfile Corp. - January 25, 2021) - Bloom...
Alleviant Medical Receives Breakthrough Device Designation From FDA for Transcatheter Technology
Innovative technology offers an implant-free approach for individuals with chronic heart failure AUSTIN, Texas--(BUSINESS WIRE)--Alleviant Medical Inc., a privately-held medical...
Immunicom Makes StartUpCity’s Global “Ten Most Promising 2020 Biotech Startups”
Company praised for efforts to create “affordable and effective” novel cancer immunotherapies and promising technology platform with broad potential to...
Israeli Technology Leading World Out of COVID-19 Crisis
TEL AVIV, Israel, Jan. 25, 2021 /PRNewswire/ -- The IMPROVATE Innovation Conference held online and in Tel Aviv last week dealt...
Dr. Raymond Rezaie Provides Tips to Help Decrease Your Chances of Getting Coronavirus
Dr. Raymond Rezaie Offers Practical Tips to Help Decrease Your Chances of Getting COVID-19 MONTREAL, QC / ACCESSWIRE / January...
Endoscopy Ultrasound Market Growth Underpinned by Heightened Cancer Research Initiatives: Fact.MR
International level coalitions amongst healthcare organizations, governments and research institutions are expected to generate credible grounds for expansion ROCKVILLE, MD...
Novamind to Present at Inaugural KCSA Psychedelics Investor Conference
Features virtual presentations by eminent psychedelics companies and industry leaders TORONTO, ON / ACCESSWIRE / January 25, 2021 / Novamind...
Halberd Corporation’s Research Breakthrough – Qualitative & Quantitative Measurement of Covid-19 Antigens and/or Antibodies
JACKSON CENTER, PA / ACCESSWIRE / January 25, 2021 / Halberd Corp. (OTC PINK:HALB) research produces qualitative and quantitative diagnostic...
COVID Lockdowns Raise Questions About How To Get Suboxone
Tara Healthcare LLC offers Opioid recovery alternatives during the expected COVID lockdowns over the next couple of months. NEW YORK,...
Sonnet BioTherapeutics Announces the Successful Completion of a Non-human Primate Toxicology Study of SON-080
No adverse effects observed at all doses tested Using the results of this study, combined with previously compiled clinical safety...
Theralase Launches Third Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / January 25, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
GB Sciences Begins Proof of Concept Studies with Michigan State University for the Treatment of Cytokine Release Syndrome
LAS VEGAS, NV / ACCESSWIRE / January 25, 2021 / GB Sciences, Inc. (OTCQB:GBLX), through GBS Global Biopharma, Inc. ("GBS"),...